Effects of NMDA receptor modulators on a blood-brain barrier in vitro model

Brain Research

Volumn 1394, Issue , 2011, Pages 49-61

  Neuhaus, Winfried ^a,b   Freidl, Michael ^b   Szkokan, Phillip ^b   Berger, Michael ^c   Wirth, Michael ^b   Winkler, Johannes ^b   Gabor, Franz ^b   Pifl, Christian ^c   Noe, Christian R ^b  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b UNIVERSITY OF VIENNA   (Austria)

^c Medical University of Vienna   (Austria)

Author keywords

Blood brain barrier; D APV; ECV304; Glutamate; MK801; NMDA; NMDA receptor

Indexed keywords

DIZOCILPINE; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; OCCLUDIN; PROTEIN ZO1;

ARTICLE; BLOOD BRAIN BARRIER; CALCIUM CELL LEVEL; CELL FUNCTION; CELL MEMBRANE; ELECTRIC RESISTANCE; HUMAN; HUMAN CELL; IN VITRO STUDY; MEMBRANE BINDING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

2-AMINO-5-PHOSPHONOVALERATE; BLOOD-BRAIN BARRIER; BLOTTING, WESTERN; CALCIUM; CELL LINE; DIZOCILPINE MALEATE; ENDOTHELIAL CELLS; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMIC ACID; HUMANS; MEMBRANE PROTEINS; PHOSPHOPROTEINS; RECEPTORS, N-METHYL-D-ASPARTATE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79956288365     PISSN: 00068993     EISSN: 00068993     Source Type: Journal    
DOI: 10.1016/j.brainres.2011.04.003     Document Type: Article

References (59)

1. Abbott, N.J., Rönnbäck, L., Hansson, E., 2006. Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 7, 41-53.
2. Albensi, B.C., 2007. TheNMDAreceptor/ion channel complex: a drug target for modulating synaptic plasticity and excitotoxicity. Curr. Pharm. Des 2007 (13), 1-10.
3. Andras, I.E., Deli, M.A., Veszelka, S., Hayashi, K., Hennig, B., Toborek, M., 2007. The NMDA and AMPA/KA receptors are involved in glutamate-induced alterations of occludin expression and phosphorylation in brain endothelial cells. J. Cereb. Blood Flow Metab. 27, 1431-1443.
4. Arias, H.R., McCardy, E.A., Blanton, M.P., 2001. Characterization of the dizocilpine binding site on the nicotinic acetylcholine receptor. Mol. Pharmacol. 59, 1051-1060.
5. Bauer, B., Hartz, A.M.S., Pekcec, A., Toellner, K., Miller, D.S., Potschka, H., 2008. Seizure-induced up-regulation of p-glycoprotein at the blood-brain barrier through glutamate and cyclooxygenase-2 signaling. Mol. Pharmacol. 73, 1444-1453.
6. Benda, P., Lightbody, J., Sato, G., Levine, L., Sweet, W., 1968. Differential rat glial cell strain in tissue culture. Science 161, 370-371.
7. Benveniste, H., Drejer, J., Schousboe, A., Diemer, N.H., 1984. Elevation of extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43, 1369-1374. (Pubitemid 15205893)
8. Betzen, C., White, R., Zehendner, C.M., Pietrokowski, E., Bender, B., Luhmann, H.J., Kuhlmann, C.R., 2009. Oxidative stress upregulates the NMDA receptor on cerebrovascular endothelium. Free Radic. Biol. Med. 47, 1212-1220.
9. Bradford, M.M., 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
10. Buchstaller, H.P., Siebert, C.D., Steinmetz, R., Frank, I., Berger, M.L., Gottschlich, R., Leibrock, J., Krug, M., Steinhilber, D., Noe, C.R., 2006. Synthesis of thieno[2,3-b]pyridinones acting as cytoprotectants and as inhibitors of [3H]glycine binding to the N-methyl-D-aspartate (NMDA) receptor. J. Med. Chem. 49, 864-871.
11. Butt, A.M., Jones, H.C., Abbott, N.J., 1990. Electrical resistance across the blood-brain barrier in anaesthetized rats: a developmental study. J. Physiol. 429, 47-62. (Pubitemid 20327537)
12. Dolman, D.E.M., Anderson, P., Rollison, C., Abbott, N.J., 1998. Characterisation of a new in vitro model of the blood-brain barrier (BBB). J. Physiol. 505, 56-57.
13. Domoki, F., Kis, B., Gaspar, T., Bari, F., Busija, D.W., 2008. Cerebromicrovascular endothelial cells are resistant to L-glutamate. Am. J. Physiol. Regul. Integr. Comp. Physiol. 295, R1099-R1108.
14. Easton, A.S., Abbott, N.J., 2002. Bradykinin increases permeability by calcium and 5-lipoxygenase in ECV304/C6 cell culture model of the blood-brain barrier. Brain Res. 953, 157-169. (Pubitemid 35217817)
15. Feuerbach, D., Loetscher, E., Neurdin, S., Koller, M., 2010. Comparative pharmacology of the human NMDA-receptor subtypes R1-2C and R1-2D using an inducible expression system. Eur. J. Pharmacol. 637, 46-54.
16. Hardingham, G.E., 2009. Colworth medal lecture: coupling of the NMDA receptor to neuroprotective and neurodestructive events. Biochem. Soc. Trans. 37, 1147-1160.
17. Henson, M.A., Roberts, A.C., Perez-Otano, I., Philpot, B.D., 2010. Influence of the NR3A subunit on NMDA receptor functions. Progr. Neurobiol. 91, 23-37.
18. Hurst, R.D., Fritz, I.B., 1996. Properties of an immortalized vascular endothelial/glioma cell co-culture model of the blood-brain barrier. J. Cell. Physiol. 167, 81-88.
19. Ikonomidou, C., Turski, L., 2002. Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? Lancet Neurol. 1, 383-386.
20. Jantas, D., Lason, W., 2009. Different mechanisms of NMDA-mediated protection against neuronal apoptosis: a stimuli-dependent effect. Neurochem. Res. 34, 2040-2054.
21. Joo, F., 1996. Endothelial cells of the brain and other organ systems: some similarities and differences. Prog. Neurobiol. 48, 255-273.
22. Kiedrowski, L., Brooker, G., Costa, E., Wroblewski, J.T., 1994. Glutamate impairs neuronal calcium extrusion while reducing sodium gradient. Neuron 12, 295-300. (Pubitemid 24071295)
23. Kloda, A., Martinac, B., Adams, D.J., 2007. Polymodal regulation of NMDA receptor channels. Channels 1, 334-343.
24. Köhr, G., 2006. NMDA receptor function: subunit composition versus spatial distribution. Cell Tissue Res. 326, 439-446. (Pubitemid 44435819)
25. Krizbai, I.A., Deli, M.A., Pestenacz, A., Siklos, L., Szabo, C.A., Andras, I., Joo, F., 1998. Expression of glutamate receptors on cultured cerebral endothelial cells. J. Neurosci. Res. 54, 814-819.
26. Kuchler-Bopp, S., Delaunoy, J.P., Artault, J.C., Zaepfel, M., Dietrich, J.B., 1999. Astrocytes induce several blood-brain barrier properties in non-neural endothelial cell. Neuroreport 10, 1347-1353. (Pubitemid 29403721)
27. Kuhlmann, C.R.W., Gerigk, M., Bender, B., Closhen, D., Lessmann, V., Luhmann, H.J., 2008. Fluvastatin prevents glutamate-induced blood-brain-barrier disruption in vitro. Life Sci. 82, 1281-1287.
28. Legros, H., Launay, S., Roussel, B.D., Marcou-Labarre, A., Calbo, S., Catteau, J., Leroux, P., Boyer, O., Ali, C., Marret, S., Vivien, D., Laudenbach, V., 2009. Newborn- and adult-derived brain microvascular endothelial cells show age-related differences in phenotype and glutamate-evoked protease release. J. Cereb. Blood Flow Metab. 29, 1146-1158.
29. Li, J., McRoberts, J.A., Ennes, H.S., Trevisani, M., Nicoletti, P., Mittal, Y., Mayer, E.A., 2006. Experimental colitis modulates the functional properties ofNMDAreceptors in dorsal root ganglia neurons. Am. J. Physiol. Gastrointest. Liver Physiol. 291, G219-G228.
30. Madry, C., Mesic, I., Bartholomäus, I., Nicke, A., Betz, H., Laube, B., 2007. Principal role of NR3 subunits in NR1/NR3 excitatory glycine receptor function. Biochem. Biophys. Res. Comm. 354, 102-108.
31. Merrit, J.E., Carthy, S.A., Mc Davies, M.P.A., Moores, K.E., 1990. Use of fluo-3 measure cytosolic Ca2+ in platelets and neutrophils. Biochem. J. 269, 513-519.
32. Minagar, A., Alexander, J.S., Kelley, R.E., Harper, M., Jennings, M.H., 2009. Proteomic analysis of human cerebral endothelial cells activated by glutamate/MK-801: significance in ischemic stroke injury. J. Mol. Neurosci. 38, 182-192.
33. Minta, A., Kao, J.P.Y., Tsien, R., 1989. Fluorescent indicators for cytosolic calcium based on rhodamine and fluorescein chromophores. J. Biol. Chem. 264, 8171-8178.
34. Morley, P., Small, D.L., Murray, C.L., Mealing, G.A., Poulter, M.O., Durkin, J.P., Stanimirovic, D.B., 1998. Evidence that functional glutamate receptors are not expressed on rat or human cerebromicrovascular endothelial cells. J. Cereb. Blood Flow Metab. 18, 396-406.
35. Naples, M.A., Hampson, D.R., 2001. Pharmacological profiles of the metabotropic glutamate receptor ligands. Neuropharmacology 40, 170-177.
36. Neuhaus, W., Noe, C.R., 2009. Transport at the blood-brain barrier. In: Ecker, G., Chiba, P. (Eds.), Transporters as Drug Carriers: Structure, Function, Substrates: 44 (Methods and Principles in Medicinal Chemistry). Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany, pp. 263-298.
37. Neuhaus, W., Bogner, E., Wirth, M., Trzeciak, J., Lachmann, B., Gabor, F., Noe, C.R., 2006. A novel tool to characterize paracellular transport: the APTS-dextran ladder. Pharm. Res. 23, 1491-1501.
38. Neuhaus, W., Plattner, V.E., Wirth, M., Germann, B., Lachmann, B., Gabor, F., Noe, C.R., 2008a. Validation of in vitro cell culture models of the blood-brain barrier: tightness characterization of two promising cell lines. J. Pharm. Sci. 97, 5158-5175.
39. Neuhaus, W., Wirth, M., Plattner, V.E., Germann, B., Gabor, F., Noe, C.R., 2008b. Expression of claudin-1, claudin-3 and claudin-5 in human blood-brain barrier mimicking cell line ECV304 is inducible by glioma-conditioned media. Neurosci. Lett. 446, 59-64.
40. Neuhaus, W., Trauner, G., Gruber, D., Oelzant, S., Klepal, W., Kopp, B., Noe, C.R., 2008c. Transport of a GABAA receptor modulator and its derivatives from Valeriana officinalis L. s. l. across an in vitro cell culture model of the blood-brain barrier. Planta Med. 74, 1338-1344.
41. Neuhaus, W., Germann, B., Plattner, V.E., Gabor, F., Wirth, M., Noe, C.R., 2009. Alteration of the glycocalyx of two blood-brain barrier mimicking cell lines is inducible by glioma conditioned media. Brain Res. 1279, 82-89.
42. Patton, A.J., Genever, P.G., Birch, M.A., Suva, L.J., Skerry, T.M., 1998. Expression of an N-methyl-D-aspartate-type receptor by human and rat osteoblasts and osteoclasts suggests a novel glutamate signaling pathway in bone. Bone 22, 645-649. (Pubitemid 28284613)
43. Pifl, C., Hornykiewicz, O., Giros, B., Caron, M.G., 1996. Catecholamine transporters and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: studies comparing the cloned human noradrenaline and human dopamine transporter. J. Pharmacol. Exp. Ther. 277, 1437-1443.
44. Poetsch, V., Neuhaus, W., Noe, C.R., 2010. Serum-derived immunoglobulins neutralize adverse effects of amyloid-β peptide on the integrity of a blood-brain barrier in vitro model. J. Alzheimer's Dis. 21, 303-314.
45. Reijerkerk, A., Kooij, G., van der Pol, S.M., Leyen, T., Lakeman, K., van Het Hof, B., Vivien, D., de Vries, H.E., 2010. The NR1 subunit of NMDA receptor regulates monocyte transmigration through the brain endothelial cell barrier. J. Neurochem. 113, 447-453.
46. Scism, J.L., Laska, D.A., Horn, J.W., Gimple, J.L., Pratt, S.E., Shepard, R.L., Dantzig, A.H., Wrighton, S.A., 1999. Evaluation of an in vitro coculturemodel for the blood-brain barrier: comparison of human umbilical vein endothelial cells (ECV304) and rat glioma cells (C6) from two commercial sources. In Vitro Cell. Dev. Biol. Anim. 35, 580-592. (Pubitemid 30007655)
47. Sharp, C.D., Hines, I., Houghton, J., Warren, A., Jackson IV, T.H., Jawahar, A., Nanda, A., Elrod, J.W., Long, A., Chi, A., Minagar, A., Alexander, J.S., 2003. Glutamate causes a loss in human cerebral endothelial barrier integrity through activation of NMDA receptor. Am. J. Physiol. Heart Circ. Physiol. 285, H2592-H2598.
48. Sharp, C.D., Houghton, J., Elrod, J.W., Warren, A., Jackson IV, T.H., Jawahar, A., Nanda, A., Minagar, A., Alexander, J.S., 2005. N-methyl-D-aspartate receptor activation in human cerebral endothelium promotes intracellular oxidant stress. Am. J. Physiol. Heart Circ. Physiol. 288, H1893-H1899.
49. Singh, J., Kaur, G., 2005. Neuroprotection mediated by subtoxic dose of NMDA in SH-SY5Y neuroblastoma cultures: activity-dependent regulation of PSA-NCAM expression. Brain Res. Mol. Brain Res. 137 (1-2), 223-234.
50. Singh, J., Kaur, G., 2009. Transcriptional regulation of PSA-NCAM expression by NMDA receptor activation in RA-differentiated C6 glioma cultures. Brain Res. Bull. 79, 157-168.
51. Sommerauer, C., 2010. Molecular pharmacology of amantadine and related substances in cells heterologously expressing human transporters and receptors. Master thesis, Medical University of Vienna, Brain Research Center
52. Tan, K.H., Dobbie, M.S., Felix, R.A., Barrand, M.A., Hurst, R.D., 2001. A comparison of the induction of immortalized endothelial cell impermeability by astrocytes. Neuroreport 12, 1329-1334. (Pubitemid 32476123)
53. 2+ in cerebral cortex neurons is transient in immature cells but permanent in mature cells. J. Neurochem. 53, 1316-1319.
54. Winkler, J., Gilbert, M., Kocourkov, A., Stessl, M., Noe, C.R., 2008. 2-O-Lysylaminohexyl oligonucleotides: modifications of antisense and siRNA. ChemMedChem 3, 102-110.
55. Wright, R.A., Arnold, M.B., Wheeler, W.J., Ornstein, P.L., Schoepp, D.D., 2001. [3H]LY341495 binding to group II metabotropic glutamate receptors in rat brain. J. Pharmacol. Exp. Ther. 298, 453-460.
56. Youdim, K.A., Dobbie, M.S., Kuhnle, G., Proteggente, A.R., Abbott, N.J., Rice-Evans, C., 2003. Interaction between flavonoids and the blood-brain barrier: in vitro studies. J. Neurochem. 85, 180-192. (Pubitemid 36389708)
57. Zehendner, C.M., Luhmann, H.J., Kuhlmann, C.R., 2009. Studying the neurovascular unit: an improved blood-brain barrier model. J. Cereb. Blood Flow Metab. 29, 1879-1884.
58. Zhang, J., Xiao, P., Zhang, X., 2009. Phosphatidylserine externalization in caveolae inhibits Ca2+ efflux through plasma membrane Ca2+-ATPase in ECV304. Cell Calcium 45, 177-184.
59. Zhu, H.J., Liu, G.Q., 2004. Glutamate up-regulates P-glycoprotein expression in rat brain microvessel endothelial cells by an NMDA receptor-mediated mechanism. Life Sci. 75, 1313-1322.